MedKoo Cat#: 532774 | Name: TRC051384
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

TRC051384 is a inducer of heat shock protein Hsp70. It reduces stroke-associated neuronal injury and increases survival in a rat model of transient ischemic stroke. TRC051384 enhances Hsp72 expression in neurons and glial cells.

Chemical Structure

TRC051384
TRC051384
CAS#867164-40-7

Theoretical Analysis

MedKoo Cat#: 532774

Name: TRC051384

CAS#: 867164-40-7

Chemical Formula: C25H31N5O4

Exact Mass: 465.2376

Molecular Weight: 465.55

Elemental Analysis: C, 64.50; H, 6.71; N, 15.04; O, 13.75

Price and Availability

Size Price Availability Quantity
50mg USD 550.00
100mg USD 950.00
200mg USD 1,650.00
500mg USD 2,650.00
1g USD 3,450.00
2g USD 5,450.00
5g USD 8,950.00
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
TRC051384; TRC 051384; TRC-051384.
IUPAC/Chemical Name
N-[2-(4-Morpholinyl)ethyl]-N'-[4-[3-[6-(4-morpholinyl)-2-pyridinyl]-1-oxo-2-propen-1-yl]phenyl]urea
InChi Key
SQTSPANZQDCPLB-CMDGGOBGSA-N
InChi Code
InChI=1S/C25H31N5O4/c31-23(9-8-21-2-1-3-24(27-21)30-14-18-34-19-15-30)20-4-6-22(7-5-20)28-25(32)26-10-11-29-12-16-33-17-13-29/h1-9H,10-19H2,(H2,26,28,32)/b9-8+
SMILES Code
O=C(NC1=CC=C(C(/C=C/C2=NC(N3CCOCC3)=CC=C2)=O)C=C1)NCCN4CCOCC4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 465.55 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Chen T, Tao YN, Wu Y, Ren X, Li YF, Wang YH. HSP70 attenuates neuronal necroptosis through the HSP90α-RIPK3 pathway following neuronal trauma. Mol Biol Rep. 2023 Sep;50(9):7237-7244. doi: 10.1007/s11033-023-08619-7. Epub 2023 Jul 7. PMID: 37418085. 2: Zhang S, Liu W, Wang P, Hu B, Lv X, Chen S, Wang B, Shao Z. Activation of HSP70 impedes tert-butyl hydroperoxide (t-BHP)-induced apoptosis and senescence of human nucleus pulposus stem cells via inhibiting the JNK/c-Jun pathway. Mol Cell Biochem. 2021 May;476(5):1979-1994. doi: 10.1007/s11010-021-04052-1. Epub 2021 Jan 28. PMID: 33511552. 3: Xu G, Li J, Zhang D, Su T, Li X, Cui S. HSP70 inhibits pig pituitary gonadotrophin synthesis and secretion by regulating the corticotropin-releasing hormone signaling pathway and targeting SMAD3. Domest Anim Endocrinol. 2021 Jan;74:106533. doi: 10.1016/j.domaniend.2020.106533. Epub 2020 Aug 1. PMID: 32992141. 4: Allende M, Molina E, Guruceaga E, Tamayo I, González-Porras JR, Gonzalez- López TJ, Toledo E, Rabal O, Ugarte A, Roldán V, Rivera J, Oyarzabal J, Montes R, Hermida J. Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk. Cardiovasc Res. 2016 Jun 1;110(3):309-18. doi: 10.1093/cvr/cvw049. Epub 2016 Mar 14. PMID: 26976620. 5: Mohanan A, Deshpande S, Jamadarkhana PG, Kumar P, Gupta RC, Chauthaiwale V, Dutt C. Delayed intervention in experimental stroke with TRC051384--a small molecule HSP70 inducer. Neuropharmacology. 2011 May;60(6):991-9. doi: 10.1016/j.neuropharm.2010.12.003. Epub 2010 Dec 16. PMID: 21167846.